AR074318A1 - Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. - Google Patents
Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.Info
- Publication number
- AR074318A1 AR074318A1 ARP090104358A ARP090104358A AR074318A1 AR 074318 A1 AR074318 A1 AR 074318A1 AR P090104358 A ARP090104358 A AR P090104358A AR P090104358 A ARP090104358 A AR P090104358A AR 074318 A1 AR074318 A1 AR 074318A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- substituted
- fluorine
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Reivindicación 1: Un nuevo compuesto de pirazolona, caracterizado por la fórmula 1 donde R1 representa un derivado de fenilo de fórmula (a), (b) o (c) donde R2 es alcoxi C1-2 o alcoxi C1-2 que está completamente o predominantemente substituido por flúor, R3 es alcoxi C1-2, cicloalcoxi C3-5, cicloalquil C3-5-metoxi, o alcoxi C1-2 que está completamente o predominantemente substituido por flúor, R4 es alcoxi C1-2 o alcoxi C1-2 que está completamente o predominantemente substituido por flúor; R5 es alquilo C1-2 y R6 es hidrógeno o alquilo C1-2, o R5 y R6, conjuntamente y con inclusión de los dos átomos de carbono a los cuales están ligados, forman un anillo hidrocarbonado de 5 o 6 miembros ligado en spiro, R7 es alcoxi C1-2 o alcoxi C1-2 que está completamente o predominantemente substituido por flúor, R8 es alquilo C1-2 y R9 es hidrógeno o alquilo C1-2, o R8 y R9 conjuntamente y con inclusión de los dos átomos de carbono a los cuales están ligados, forman un anillo hidrocarbonado de 5 o 6 miembros ligado en spiro, R10 es alquilo C1-3 y R11 es alquilo C1-3, o R10 y R11, conjuntamente con el átomo de carbono al cual están ligados, forman un anillo hidrocarbonado de 3, 4, 5 o 6 miembros ligado en spiro, A es C(O) o S(O)2, R12 es fenilo, naftalenilo, piridinilo, quinolinilo, isoquinolinilo, quinoxalinilo, 1,6-naftiridinilo, 1,8- naftiridinilo, indolilo, fenilo substituido por R13, R14, R15 y R16, piridinilo substituido por R17 y R18, naftalenilo substituido por R19 y R20, quinolinilo sustituido por R21 o indolilo sustituido por R22, donde R13 es halógeno, ciano, hidroxi, hidroxicarbonilo, alquilo C1-4, trifluorometilo, alcoxi C1-4, alcoxi C1-4 sustituido completamente o predominantemente por flúor, cicloalquil C3-7-oxi, cicloalquil C3-7-metoxi, benciloxi, 2,6-diclorobenciloxi, amino, mono- o di- alquil C1-4-amino, aminocarbonilo, mono- o di- alquil C1-4-aminocarbonilo, aminocarbonil-alcoxi C1-4, alquil C1-4-carbonilamino, alquil C1-4-carboniloxi, alcoxi C1-4-carbonilo o alcoxi C1-4-carbonil-alcoxi C1-4, R14 es H, halógeno, alquilo C1-4, alcoxi C1-4, alcoxi C1-4 completamente o predominantemente sustituido por flúor; alcoxi C1-4-carbonilo, amino o mono- o di- alquil C1-4-amino; R15 es H, halógeno o alquilo C1-4, R16 es H o alquilo C1-4, R17 es halógeno, alquilo C1-4, trifluorometilo, alcoxi C1-4, amino, mono- o di- alquil-C1-4-amino, piperidinilo o morfolinilo, R18 es hidrógeno, halógeno, alquilo C1-4 o alcoxi C1-4, R19 es halógeno, hidroxi, alquilo C1-4, alcoxi C1-4, amino o mono- o di-alquil C1-4-amino, R20 es hidrógeno, alquilo C1-4 o alcoxi C1-4, R21 es alquilo C1-4; R22 es alquilo C1-4, o una sal, un estereoisómero o una sal de un estereoisómero del compuesto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08169143 | 2008-11-14 | ||
| US19333308P | 2008-11-19 | 2008-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074318A1 true AR074318A1 (es) | 2011-01-05 |
Family
ID=40427227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104358A AR074318A1 (es) | 2008-11-14 | 2009-11-11 | Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8609848B2 (es) |
| EP (1) | EP2356103B1 (es) |
| JP (1) | JP5599405B2 (es) |
| KR (1) | KR20110082616A (es) |
| CN (1) | CN102369194B (es) |
| AR (1) | AR074318A1 (es) |
| AU (1) | AU2009315615A1 (es) |
| BR (1) | BRPI0921335A8 (es) |
| CA (1) | CA2742922C (es) |
| CO (1) | CO6331469A2 (es) |
| EA (1) | EA018585B1 (es) |
| EC (1) | ECSP11011034A (es) |
| ES (1) | ES2553754T3 (es) |
| GE (1) | GEP20135918B (es) |
| HK (1) | HK1167406A1 (es) |
| IL (1) | IL212700A0 (es) |
| MA (1) | MA32885B1 (es) |
| ME (1) | ME01134B (es) |
| MX (1) | MX2011005030A (es) |
| MY (1) | MY154019A (es) |
| NZ (1) | NZ593262A (es) |
| PE (1) | PE20110539A1 (es) |
| TW (1) | TWI460172B (es) |
| UA (1) | UA105910C2 (es) |
| WO (1) | WO2010055083A1 (es) |
| ZA (1) | ZA201102028B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR074318A1 (es) * | 2008-11-14 | 2011-01-05 | Nycomed Gmbh | Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. |
| US20150322049A1 (en) * | 2012-12-13 | 2015-11-12 | Ludwig Aigner | Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2903460A (en) * | 1956-04-07 | 1959-09-08 | Sandoz Ag | Pyrazolone derivatives |
| US4550119A (en) | 1983-05-23 | 1985-10-29 | Warner-Lambert Company | 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones |
| WO1998031674A1 (en) | 1997-01-15 | 1998-07-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinones |
| EA200300836A1 (ru) * | 2001-02-15 | 2004-02-26 | Алтана Фарма Аг | Производные фталазинон-пиперидина в качестве ингибиторов pde4 |
| CA2445233A1 (en) | 2001-04-25 | 2002-10-31 | Altana Pharma Ag | Phthalazinones derivatives useful as pde4/7 inhibitors |
| CA2494650A1 (en) | 2002-08-10 | 2004-03-04 | Altana Pharma Ag | Pyridazinone-derivatives as pde4 inhibitors |
| JP4555684B2 (ja) * | 2002-08-10 | 2010-10-06 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン |
| AU2003255376A1 (en) | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-derivatives as pde4 inhibitors |
| WO2005075457A1 (en) | 2004-02-04 | 2005-08-18 | Altana Pharma Ag | Phthalazinone-derivatives as pde4 inhibitors |
| AU2005210042B2 (en) * | 2004-02-04 | 2011-04-21 | Takeda Gmbh | 2-(piperidin-4-yl) -4, 5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| PL2589599T4 (pl) * | 2004-03-03 | 2015-06-30 | Takeda Gmbh | Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4 |
| KR100907354B1 (ko) | 2004-05-18 | 2009-07-10 | 쉐링 코포레이션 | Ｐｄｅ4 억제제로서 유용한 치환된 2-퀴놀릴-옥사졸 |
| BRPI0707537A2 (pt) * | 2006-02-07 | 2011-05-03 | Wyeth Corp | inibidores de 11-beta hsd1 |
| ES2374337T3 (es) * | 2007-05-16 | 2012-02-15 | Nycomed Gmbh | Derivados de pirazolona como inhibidores de pde4. |
| US20100130738A1 (en) * | 2007-06-19 | 2010-05-27 | Yasushi Kohno | Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| AR074318A1 (es) * | 2008-11-14 | 2011-01-05 | Nycomed Gmbh | Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. |
-
2009
- 2009-11-11 AR ARP090104358A patent/AR074318A1/es unknown
- 2009-11-12 AU AU2009315615A patent/AU2009315615A1/en not_active Abandoned
- 2009-11-12 ES ES09752352T patent/ES2553754T3/es active Active
- 2009-11-12 CA CA2742922A patent/CA2742922C/en not_active Expired - Fee Related
- 2009-11-12 MX MX2011005030A patent/MX2011005030A/es active IP Right Grant
- 2009-11-12 NZ NZ593262A patent/NZ593262A/xx not_active IP Right Cessation
- 2009-11-12 EP EP09752352.6A patent/EP2356103B1/en active Active
- 2009-11-12 US US13/128,051 patent/US8609848B2/en not_active Expired - Fee Related
- 2009-11-12 UA UAA201107341A patent/UA105910C2/uk unknown
- 2009-11-12 CN CN200980145860.1A patent/CN102369194B/zh not_active Expired - Fee Related
- 2009-11-12 PE PE2011000973A patent/PE20110539A1/es not_active Application Discontinuation
- 2009-11-12 EA EA201100740A patent/EA018585B1/ru not_active IP Right Cessation
- 2009-11-12 KR KR1020117013038A patent/KR20110082616A/ko not_active Application Discontinuation
- 2009-11-12 WO PCT/EP2009/065031 patent/WO2010055083A1/en active Application Filing
- 2009-11-12 ME MEP-2011-81A patent/ME01134B/me unknown
- 2009-11-12 JP JP2011536009A patent/JP5599405B2/ja not_active Expired - Fee Related
- 2009-11-12 BR BRPI0921335A patent/BRPI0921335A8/pt not_active IP Right Cessation
- 2009-11-12 MY MYPI2011001414A patent/MY154019A/en unknown
- 2009-11-12 GE GEAP200912248A patent/GEP20135918B/en unknown
- 2009-11-13 TW TW098138693A patent/TWI460172B/zh active
-
2011
- 2011-03-17 ZA ZA2011/02028A patent/ZA201102028B/en unknown
- 2011-05-05 IL IL212700A patent/IL212700A0/en unknown
- 2011-05-06 EC EC2011011034A patent/ECSP11011034A/es unknown
- 2011-05-12 CO CO11058443A patent/CO6331469A2/es active IP Right Grant
- 2011-06-08 MA MA33922A patent/MA32885B1/fr unknown
-
2012
- 2012-08-21 HK HK12108195.2A patent/HK1167406A1/xx not_active IP Right Cessation
-
2013
- 2013-11-15 US US14/080,881 patent/US9340522B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR068846A1 (es) | Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer | |
| PE20181304A1 (es) | Derivados de indol n-sustituidos como moduladores de los receptores de pge2 | |
| AR085039A1 (es) | DERIVADOS DE PURINA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA PREPARACION DE MEDICAMENTOS PARA TRATAR ENFERMEDADES MODULADAS POR LA INHIBICION DE LA PI3K DE CLASE I Y/O mTOR | |
| AR066881A1 (es) | Derivados de oxadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de trastornos asociados con la disfuncion del glutamato. | |
| AR059901A1 (es) | Compuestos de tetrahidropiridotienopirimidina utiles para tratar o prevenir trastornos proliferativos celulares. | |
| AR056215A1 (es) | Derivados de indol como inhibidores de la proteina activadora de 5-lipoxigenasa (flap), composiciones farmaceuticas que los comprenden y su uso en el tratamiento de trastornos respiratorios e inflamatorios | |
| CR8859A (es) | Derivados de piridina | |
| AR061567A1 (es) | Compuestos puros enantiomericamente para el tratamiento de desordenes proliferativos | |
| CO6251260A2 (es) | Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c. | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR051326A1 (es) | Pirazolobenzodiazepinas disustituidas | |
| CO6210729A2 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona procedimientos para su preparacion y su uso como agente farmaceutico | |
| CO5300399A1 (es) | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| AR045761A1 (es) | Derivados de 2-piridona como inhibidores de elastasa de neutrofilos | |
| EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| AR084913A1 (es) | Derivados de aril-benzocicloalquil-amida | |
| CL2012000042A1 (es) | Compuestos derivados de imidazo[1,2-a]pirazin-7-il; composición farmacéutica que comprende a uno de los compuestos; y uso de uno de los compuestos en la preparación de un medicamento útil para tratar una enfermedad relacionada con el género plasmodium en un sujeto. | |
| PE20091425A1 (es) | Derivados de aminotiazol | |
| AR080467A1 (es) | Derivados tetrazolicos moduladores selectivos de receptores cb2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del dolor y otras enfermedades | |
| AR060535A1 (es) | Pirido-piridazinonas y ftalazinonas como antagonistas duales de los receptores h1 y h3 de histamina | |
| AR099640A1 (es) | Derivados de pirrolopiridina o pirazolopiridina | |
| BRPI0907122B8 (pt) | compostos de piridoindóis (1-azinona) substituídos, composição farmacêutica compreendendo os referidos compostos, e usos dos mesmos | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |